Literature DB >> 2438942

Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules.

H M Shulman, A M Gown, D J Nugent.   

Abstract

The authors immunostained autopsy liver tissue from 31 marrow transplant recipients, 19 with hepatic veno-occlusive disease (VOD) and 12 without VOD. A panel of monoclonal and polyclonal antibodies was used to characterize the materials within the occluded venous lesions and to define the location and types of injured cells. Most patients with early VOD (survival less than 50 days, n = 11) had dense periadventitial and intramural immunostaining of terminal hepatic and sublobular central venules (CV) with anti-Factor VIII (9/11) and anti-fibrinogen (4/4) but had no immunostaining with antibody to platelet GPIb. Early VOD patients also had marked loss of Zone 3 hepatocyte cytokeratin (8/9) versus late VOD (1/5) or non-VOD (2/7). Patients with late VOD lesions (n = 8, survival greater than 50 days) had increased collagen within occluded VOD lesions. Type III much greater than Type I, and increased sinusoidal collagens Types I, III, and IV. These studies and other data suggest the following events in the genesis of VOD. Initial injury to endothelium of CV and/or sinusoids and possibly also to Zone 3 hepatocytes triggers the coagulation cascade in the periadventitial zone of CV. The late sequela, collagenous CV occlusion, results from activated mural myofibroblasts and/or embolized Ito cells and hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438942      PMCID: PMC1899766     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

1.  Aplastic anemia (AA) treated by allogeneic marrow transplantation: the Seattle experience.

Authors:  R Storb; P L Weiden; R Prentice; C D Buckner; R A Clift; A B Einstein; A Fefer; F L Johnson; K G Lerner; P E Neiman; J E Sanders; E D Thomas
Journal:  Transplant Proc       Date:  1977-03       Impact factor: 1.066

2.  Effect of ionizing radiation on liver microcirculation and oxygenation.

Authors:  H I Bicher; G V Dalrymple; D Ashbrook; R Smith; D Harris
Journal:  Adv Exp Med Biol       Date:  1976       Impact factor: 2.622

3.  Endothelium and the regulation of coagulation.

Authors:  D M Stern; B Carpenter; P P Nawroth
Journal:  Pathol Immunopathol Res       Date:  1986

4.  Transplantation system for determining the clonogenic survival of parenchymal hepatocytes exposed to ionizing radiation.

Authors:  R L Jirtle; G Michalopoulos; J R McLain; J Crowley
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

5.  Covalent attachment of sulfhydryl-specific, electron spin resonance spin-labels to Fab' fragments of murine monoclonal antibodies that recognize human platelet membrane glycoproteins. Development of membrane protein specific spin probes.

Authors:  T J Kunicki; D J Nugent; R S Piotrowicz; C S Lai
Journal:  Biochemistry       Date:  1986-09-09       Impact factor: 3.162

6.  One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation.

Authors:  E D Thomas; C D Buckner; M Banaji; R A Clift; A Fefer; N Flournoy; B W Goodell; R O Hickman; K G Lerner; P E Neiman; G E Sale; J E Sanders; J Singer; M Stevens; R Storb; P L Weiden
Journal:  Blood       Date:  1977-04       Impact factor: 22.113

7.  Anticoagulation and high dose liver radiation: a preliminary report.

Authors:  C J Lightdale; J Wasser; M Coleman; M Brower; M Tefft; M Pasmantier
Journal:  Cancer       Date:  1979-01       Impact factor: 6.860

8.  HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization.

Authors:  T Tsukada; D Tippens; D Gordon; R Ross; A M Gown
Journal:  Am J Pathol       Date:  1987-01       Impact factor: 4.307

9.  An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation.

Authors:  H M Shulman; G B McDonald; D Matthews; K C Doney; K J Kopecky; J M Gauvreau; E D Thomas
Journal:  Gastroenterology       Date:  1980-12       Impact factor: 22.682

10.  Pathogenesis of veno-occlusive liver disease after radiation.

Authors:  L F Fajardo; T V Colby
Journal:  Arch Pathol Lab Med       Date:  1980-11       Impact factor: 5.534

View more
  22 in total

Review 1.  Hepatic radiation toxicity: avoidance and amelioration.

Authors:  Chandan Guha; Brian D Kavanagh
Journal:  Semin Radiat Oncol       Date:  2011-10       Impact factor: 5.934

2.  Veno-occlusive disease (VOD) in Crohn's disease (CD) treated with azathioprine.

Authors:  M Holtmann; O Schreiner; H Köhler; U Denzer; M Neurath; P R Galle; T Höhler
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

3.  On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease.

Authors:  E Carreras; A Grañena; M Navasa; M Bruguera; V Marco; J Sierra; M D Tassies; J C García-Pagán; J M Martí; J Bosch
Journal:  Ann Hematol       Date:  1993-02       Impact factor: 3.673

4.  Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: Final results from a post hoc analysis of data from an expanded-access program.

Authors:  Nancy A Kernan; Paul G Richardson; Angela R Smith; Brandon M Triplett; Joseph H Antin; Leslie Lehmann; Yoav Messinger; Wei Liang; Robin Hume; William Tappe; Robert J Soiffer; Stephan A Grupp
Journal:  Pediatr Blood Cancer       Date:  2018-06-06       Impact factor: 3.167

5.  Experience from a single paediatric transplant centre with identification of some protective and risk factors concerning the development of hepatic veno-occlusive disease in children after allogeneic hematopoietic stem cell transplant.

Authors:  N Maximova; G Ferrara; M Minute; A Pizzol; V Kiren; M Montico; M Gregori; P Tamaro
Journal:  Int J Hematol       Date:  2014-04-09       Impact factor: 2.490

6.  A nonhuman primate model of human radiation-induced venocclusive liver disease and hepatocyte injury.

Authors:  Govardhana Rao Yannam; Bing Han; Kentaro Setoyama; Toshiyuki Yamamoto; Ryotaro Ito; Jenna M Brooks; Jorge Guzman-Lepe; Csaba Galambos; Jason V Fong; Melvin Deutsch; Mubina A Quader; Kosho Yamanouchi; Rafi Kabarriti; Keyur Mehta; Alejandro Soto-Gutierrez; Jayanta Roy-Chowdhury; Joseph Locker; Michio Abe; Charles A Enke; Janina Baranowska-Kortylewicz; Timothy D Solberg; Chandan Guha; Ira J Fox
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-12-05       Impact factor: 7.038

7.  Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial.

Authors:  Paul G Richardson; Robert J Soiffer; Joseph H Antin; Hajime Uno; Zhezhen Jin; Joanne Kurtzberg; Paul L Martin; Gideon Steinbach; Karen F Murray; Georgia B Vogelsang; Allen R Chen; Amrita Krishnan; Nancy A Kernan; David E Avigan; Thomas R Spitzer; Howard M Shulman; Donald N Di Salvo; Carolyn Revta; Diane Warren; Parisa Momtaz; Gary Bradwin; L J Wei; Massimo Iacobelli; George B McDonald; Eva C Guinan
Journal:  Biol Blood Marrow Transplant       Date:  2010-02-16       Impact factor: 5.742

Review 8.  Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome.

Authors:  Jason A Coppell; Paul G Richardson; Robert Soiffer; Paul L Martin; Nancy A Kernan; Allen Chen; Eva Guinan; Georgia Vogelsang; Amrita Krishnan; Sergio Giralt; Carolyn Revta; Nicole A Carreau; Massimo Iacobelli; Enric Carreras; Tapani Ruutu; Tiziano Barbui; Joseph H Antin; Dietger Niederwieser
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-18       Impact factor: 5.742

Review 9.  Hepatic venous outflow obstruction: three similar syndromes.

Authors:  Ulas-Darda Bayraktar; Soley Seren; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

10.  Subacute hepatic necrosis mimicking veno-occlusive disease in a patient with HFE H63D homozygosity after allogeneic hematopoietic cell transplantation with busulfan conditioning.

Authors:  Sylvia Chen; James Dane Osborn; Xinjian Chen; Michael W Boyer; George B McDonald; Gerhard Carl Hildebrandt
Journal:  Int J Hematol       Date:  2015-12       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.